MabVax Therapeutics Story

MabVax Therapeutics Holdings Inc -- USA Stock  

USD 0.78  1.57  67.02%

Macroaxis does not monitor all media channels or aggregates social signals for MabVax Therapeutics. But even though we do not provide professional-grade financial sentiment analysis on MabVax Therapeutics, we do publish noise-free headlines that can be used to derive useful patterns or even a trading strategy for MabVax Therapeutics. Please see also MabVax Therapeutics Hype Analysis, MabVax Therapeutics Correlation and MabVax Therapeutics Performance
Mabvax Therapeutics Holdings Inc Stock Price Performance in Focus
The Business UnionStock-research Ratings MabVax Therapeutics Holdings, Inc. , Digital Ally, Inc. Analyst JournalFull coverage

Read More...   

Story Momentum

This media report from distributed on December 7, 2017 was a factor to the next trading day price decrease.The trading delta at closing time against the next closing price was 1.52% . The trading delta at closing time when the story was published against the current closing price is 146.26% .

Similar stores for MabVax Therapeutics

MabVax Therapeutics Upgraded to Sell by ValuEnginenews
The Ledger GazettePaul V. Maier Sells 35448 Shares of MabVax Therapeutics Holdings, Inc. Stock Week HeraldMabVax Therapeutics Holdings, Inc. is at 2.33 per share and United Therapeutics Corporation is ... Stocks GalleryFull coverage
over two weeks ago at 
SHAREHOLDER ALERT Bronstein, Gewirtz and Grossman, LLC Announces Investigation ...
prnewswire News
PR Newswire - Jan 31, 2018 NEW YORK, Jan. 31, 2018 PRNewswire -- Attorney Advertising -- Bronstein, Gewirtz and Grossman, LLC is investigating potential claims on behalf of purchasers of MabVax Therapeutics Holdings, Inc. . Such ...
over a month ago at 
What The Crystal Ball Gazers Advise MabVax Therapeutics Holdings, Inc ...
MabVax Therapeutics Holdings, Inc. recent gain occurred on high volume with 1.24 million contracts changing hands on 10-Jan-18. Mabvax Therapeutics Holdings Inc Trending Activity with Technical Depiction - ExpertGazette
over two months ago at 
The Biggest 3 Holders Of MabVax Therapeutics Holdings, Inc.
MabVax Therapeutics Holdings, Inc. is on recovery track with 117.78 percent gain from a 1-year low price of 0.43. The company added 14.8 percent to attain the price of 0.93 on 12072017. Investors Putting MabVax Therapeutics Holdings, Inc. Under the ... - Nelson Research Investors are Watching Technical Levels on Shares of Mabvax Therapeutics ... - Hayden Business Journal

Did you try this?

Run My Watchlist Analysis Now

My Watchlist Analysis

Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Hide  View All  NextLaunch My Watchlist Analysis

Shares Owned by Institutions

Shares Owned by Institutions Comparative Analysis
  Shares Owned by Institutions 
      MabVax Therapeutics Comparables 
MabVax Therapeutics is currently under evaluation in shares owned by institutions category among related companies. Shares Owned by Institutions show percentage of the outstanding shares of stock issued by a company that are currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.